--Goldman Sachs Adjusts Arcus Biosciences' Price Target to $29 From $28, Maintains Neutral Rating
11:19AM ET 8/04/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...